Heidi Mocikova, MD, PhD

University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Department of Haematology, Prague, Czech Republic, Czech Republic

Poster(s):

• 1526 - Ibrutinib and acalabrutinib in the treatment of relapsed/refractory chronic lymphocytic leukemia: a real-world analysis from the Czech Chronic Lymphocytic Leukemia Patients Registry